Title : Enhancing incretin action for the treatment of type 2 diabetes.

Pub. Date : 2003 Oct

PMID : 14514604






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Alternatively, inhibition of DPP-IV-mediated incretin degradation represents a complementary therapeutic approach, as orally available DPP-IV inhibitors have been shown to lower glucose in experimental diabetic models and human subjects with type 2 diabetes. Glucose dipeptidyl peptidase 4 Homo sapiens
2 Alternatively, inhibition of DPP-IV-mediated incretin degradation represents a complementary therapeutic approach, as orally available DPP-IV inhibitors have been shown to lower glucose in experimental diabetic models and human subjects with type 2 diabetes. Glucose dipeptidyl peptidase 4 Homo sapiens